BIOGNOSYS
Biognosys believe that the decoding of the proteome will impact the life sciences more than the genome revolution a decade ago, and they strive to be the company that enables the routine analysis of proteomes in each research and clinical laboratory worldwide.Biognosys offers a unique next-generation solution for precise quantification of large proteomes in biological samples. Their technology provides unprecedented depth and quality of protein expression data for more effective biomarker and drug-target discovery and validation. Biognosys is a spin-off from the leading proteomics lab of Prof. Ruedi Aebersold, ETH Zurich.
BIOGNOSYS
Industry:
Biotechnology Clinical Trials Communities Genetics Health Care
Founded:
2008-09-02
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.biognosys.com
Total Employee:
101+
Status:
Active
Contact:
41 44 738 20 40
Email Addresses:
[email protected]
Total Funding:
9.03 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail PHP TransIP DNS Hostpoint
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
PM Equity Partner
PM Equity Partner investment in Series C - Biognosys
Venture Kick
Venture Kick investment in Grant - Biognosys
Venture Kick
Venture Kick investment in Grant - Biognosys
Official Site Inspections
http://www.biognosys.com Semrush global rank: 2.47 M Semrush visits lastest month: 7.19 K
- Host name: sl2012.web.hostpoint.ch
- IP address: 217.26.54.8
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "Biognosys"
Biognosys - Crunchbase Company Profile & Funding
Furthermore, Biognosys is listed among the major companies in the proteomics market, which is projected to grow significantly, implying that the company is well-positioned within a growing …See details»
Our Team - Biognosys
As VP of Global Service Sales at Biognosys, Donna and her team help biopharma and biotech customers advance their research with our CRO services. Sira Echevarría Zomeño, PhD VP, …See details»
Proteomics Solutions | Our Story - Biognosys
Biognosys’ patented next generation proteomics technology utilizes high-resolution mass spectrometry to quantify proteins with high precision and depth. Our proprietary solutions equip researchers from all fields with a multi …See details»
Biognosys Company Profile | Management and Employees List
Biognosys Profile and History. Biognosys is a leader in next-generation proteomics, dedicated to transforming life science by inventing and developing cutting-edge proteomics technology and …See details»
Who are we? - Help Center
I n Biognosys we are dedicated to transforming life sciences with next generation proteomics solutions. Founded in 2008 as a spin‑off from the lab of proteomics pioneer Ruedi Aebersold …See details»
Biognosys Company Profile 2024: Valuation, Investors …
Biognosys was founded in 2008. Where is Biognosys headquartered? Biognosys is headquartered in Zurich, Switzerland. What is the size of Biognosys? Biognosys has 71 total employees. What industry is Biognosys in? …See details»
Biognosys - Overview, News & Similar companies | ZoomInfo.com
Who is Biognosys. Biognosys is a leader in next-generation proteomics, dedicated to transforming life science by inventing and developing cutting-edge proteomics tec hnology and solutions, …See details»
Biognosys - The Org
Biognosys provides the best possible solutions to support researchers in their protein analysis needs. Biognosys. 0 followers ...See details»
Biognosys - LinkedIn
Biognosys invents and provides patented proteomics solutions at the quality, scale, and speed required to transform R&D, clinical trials, and clinical decision making. Our Solutions We offer a ...See details»
Biognosys | LinkedIn
Biognosys | 12,998 followers on LinkedIn. Transforming life sciences with cutting-edge proteomics technology and solutions | The decoding of the proteome is revolutionizing the way diseases …See details»
Drug Development | Protein Expression Profiling - Biognosys
Biognosys is committed to providing the best possible results to our customers. We consider confidentiality, proactive communication, and structured project management as key factors in …See details»
Biognosys - Products, Competitors, Financials, Employees, …
Biognosys Presents Major Innovations Across the Spectrum of Proteomics Research Applications at the HUPO World Congress. Oct 18, 2024. Search jobs 18-Oct-2024 Biognosys Presents …See details»
Biognosys - VentureRadar
BiognoSYS has developed a paradigm shifting proteomics platform. It provides patented tools to enable faster discovery of biomarkers that will play a pivotal role in tomorrow's more …See details»
Biognosys Company Overview, Contact Details & Competitors
Biognosys. Biotechnology Research Zurich, Switzerland 51-200 Employees. The decoding of the proteome is revolutionizing the way diseases are diagnosed, treated, and prevented. …See details»
Biognosys AG - Swiss Biotech
Biognosys provides next generation proteomics technology to quantify thousands of proteins for biomarker discovery or mode of action studies. The technology is available to researchers …See details»
Biognosys Expands US Footprint with New Proteomics CRO Facility …
Jan 23, 2024 ZURICH & NEWTON, Massachusetts--(BUSINESS WIRE)-- Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced today …See details»
Company Presentation | July 2022 - biognosys.com
Biognosys’ solutions are used by clients across all phases from research to clinical trials. Discovery Biology Preclinical Studies Early & Late Clinical Studies Target Deconvolution. …See details»
IonOpticks’ Custom Chromatography Column to Become
2 days ago MELBOURNE, Australia and ZURICH, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Today, IonOpticks, a world leading provider of chromatography solutions, and Biognosys, a …See details»
Biognosys and NeoGenomics Expand Global Strategic Partnership ...
Apr 11, 2022 Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced today a global strategic partnership agreement with NeoGenomics, …See details»
Biognosys Enters Collaboration with Leading Life Science …
Sep 14, 2021 Biognosys’ unique, patented technologies utilize high-resolution mass spectrometry to quantify thousands of proteins across thousands of samples with industry …See details»